学术探索
学术期刊
新闻热点
数据分析
智能评审

FIBRINOGEN AND PENTOXIFYLLINE

被引：8
作者：
BACHET, P
LANCRENON, S
CHASSOUX, G
机构：
来源：
THROMBOSIS RESEARCH | 1989年 / 55卷 / 01期
关键词：
D O I：
10.1016/0049-3848(89)90466-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：161 / 163
页数：3
相关论文
共 10 条
  • [1] FERRARI E, 1987, PHARMATHERAPEUTICA, V5, P26
  • [2] Gresser I, 1987, J Biol Regul Homeost Agents, V1, P173
  • [3] FIBRINOGEN AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY
    KANNEL, WB
    WOLF, PA
    CASTELLI, WP
    DAGOSTINO, RB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (09): : 1183 - 1186
  • [4] HEMOSTATIC FUNCTION AND ISCHEMIC-HEART-DISEASE - PRINCIPAL RESULTS OF THE NORTHWICK-PARK-HEART-STUDY
    MEADE, TW
    BROZOVIC, M
    CHAKRABARTI, RR
    HAINES, AP
    IMESON, JD
    MELLOWS, S
    MILLER, GJ
    NORTH, WRS
    STIRLING, Y
    THOMPSON, SG
    [J]. LANCET, 1986, 2 (8506) : 533 - 537
  • [5] MUGGEO M, 1983, PHARMATHERAPEUTIC S1, V3, P74
  • [6] HEMORRHEOLOGICAL IMPROVEMENT BY PENTOXIFYLLINE IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    PEREGO, MA
    SERGIO, G
    ARTALE, F
    GIUNTI, P
    DANESE, C
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1986, 10 (02) : 135 - 138
  • [7] SULLIVAN GW, 1987, PENTOXIFYLLINE LEUKO, P37
  • [8] TAKAMATSU S, 1979, PHARMATHERAPEUTICA, V2, P165
  • [9] PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY
    WARD, A
    CLISSOLD, SP
    [J]. DRUGS, 1987, 34 (01) : 50 - 97
  • [10] FIBRINOGEN AS A RISK FACTOR FOR STROKE AND MYOCARDIAL-INFARCTION
    WILHELMSEN, L
    SVARDSUDD, K
    KORSANBENGTSEN, K
    LARSSON, B
    WELIN, L
    TIBBLIN, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (08) : 501 - 505
1